FDA Approves Nexium for Children Under 12
ISSUE: MAY, 2008
The FDA has approved AstraZeneca’s proton pump inhibitor Nexium (esomeprazole magnesium) for short-term use in the treatment of children aged 1 to 11 ...
read more
Program Nets High Rate Of Metabolic Syndrome
ISSUE: APRIL, 2008
Fifty-one percent of psychiatric outpatients who received a full set of metabolic screening tests in a free, one-day program met the criteria for metabolic syndrome. This is substantially higher than the 42% rate uncovered in the large-scale, National Institutes of Health-sponsored CATIE study.
read more
Copyright ?2005 - 2008 McMahon Publishing unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.